These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38630359)

  • 1. Stem Cell Secretions as a Potential Therapeutic Agent for Autism Spectrum Disorder: A Narrative Review.
    Darwish M; El Hajj R; Khayat L; Alaaeddine N
    Stem Cell Rev Rep; 2024 Jul; 20(5):1252-1272. PubMed ID: 38630359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell-Derived Exosomes in Autism Spectrum Disorder.
    Alessio N; Brigida AL; Peluso G; Antonucci N; Galderisi U; Siniscalco D
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation.
    Wikarska A; Roszak K; Roszek K
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose-Derived Stem Cells Secretome and Its Potential Application in "Stem Cell-Free Therapy".
    Trzyna A; Banaś-Ząbczyk A
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34199330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome lncRNA IFNG-AS1 derived from mesenchymal stem cells of human adipose ameliorates neurogenesis and ASD-like behavior in BTBR mice.
    Fu Y; Zhang YL; Liu RQ; Xu MM; Xie JL; Zhang XL; Xie GM; Han YT; Zhang XM; Zhang WT; Zhang J; Zhang J
    J Nanobiotechnology; 2024 Feb; 22(1):66. PubMed ID: 38368393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice.
    Perets N; Hertz S; London M; Offen D
    Mol Autism; 2018; 9():57. PubMed ID: 30479733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review.
    Nabetani M; Mukai T; Taguchi A
    Cell Transplant; 2023; 32():9636897231163217. PubMed ID: 36999673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B.
    Perets N; Oron O; Herman S; Elliott E; Offen D
    Mol Autism; 2020 Aug; 11(1):65. PubMed ID: 32807217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of stem cells to study autism spectrum disorder.
    Ardhanareeswaran K; Coppola G; Vaccarino F
    Yale J Biol Med; 2015 Mar; 88(1):5-16. PubMed ID: 25745370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.
    Masi A; Glozier N; Dale R; Guastella AJ
    Neurosci Bull; 2017 Apr; 33(2):194-204. PubMed ID: 28238116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.
    Pistollato F; Forbes-Hernández TY; Calderón Iglesias R; Ruiz R; Elexpuru Zabaleta M; Cianciosi D; Giampieri F; Battino M
    Pharmacol Res; 2020 Feb; 152():104579. PubMed ID: 31790820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell-Derived Exosomes for Treatment of Autism Spectrum Disorder.
    Liang Y; Duan L; Xu X; Li X; Liu M; Chen H; Lu J; Xia J
    ACS Appl Bio Mater; 2020 Sep; 3(9):6384-6393. PubMed ID: 35021769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell secretome as a new booster for regenerative medicine.
    Xia J; Minamino S; Kuwabara K; Arai S
    Biosci Trends; 2019; 13(4):299-307. PubMed ID: 31527327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy.
    Rosca AM; Rayia DM; Tutuianu R
    Curr Stem Cell Res Ther; 2017; 12(2):134-138. PubMed ID: 26496883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
    Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
    Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.
    Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E
    Elife; 2024 Mar; 13():. PubMed ID: 38525876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders.
    Harrell CR; Volarevic A; Djonov V; Volarevic V
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mast cells - Cytokines axis in Autism Spectrum Disorder.
    Kovacheva E; Gevezova M; Maes M; Sarafian V
    Neuropharmacology; 2024 May; 249():109890. PubMed ID: 38431049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.